The Bradford Era

WASHINGTON (AP) — Federal regulators have uncovered new violations by the manufacturer of medical scopes recently linked to outbreaks of deadly “super...

WASHINGTON (AP) — Lyme disease conjures memories of checking for ticks at camp and fretting over bug bites after hikes in the woods. But far from a su...

WASHINGTON (AP) — Federal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti...

WASHINGTON (AP) — The maker of the much-debated painkiller Zohydro is seeking approval of a harder-to-abuse version of the drug which, if approved, co...

WASHINGTON (AP) — U.S. regulators have greenlighted a new weight-loss drug called Contrave, the third in a string of approvals for prescription medica...

WASHINGTON (AP) — The government’s top drug abuse experts are struggling to find ways to expand use of a medicine that is considered the best therapy ...

WASHINGTON (AP) — How do you have a conversation about prescription drugs that provide critical pain relief to millions of Americans yet also cause mo...

WASHINGTON (AP) — Tanning beds and sun lamps will carry new warnings that they should not be used by anyone under age 18, part of a government action ...

WASHINGTON (AP) — Federal health regulators have cleared a genetic test from Roche as the first ever U.S.-approved alternative to the Pap smear, the d...